Inorganic Chemistry
Article
(tPhTAZ)2Cl]2, except that FtPhTAZ replaced tPhTAZ. The crude
product was used for following reactions without further purification.
Synthesis of [Ir(tPhTAZ)2(bpy)]PF6 (1). [Ir(tPhTAZ)2Cl]2 (0.8 g,
0.42 mmol) and bpy (0.14 g, 0.92 mmol) were dissolved in 1,2-
dichloroethane/ethanol (10/10 mL). The mixture was refluxed under
nitrogen for 12 h. The solvent was removed under reduced pressure.
The residual was extracted with methanol (100 mL), and the
insoluble solid was removed through filtration. To the methanol
solution, NH4PF6 (1.05 g, 6.47 mmol) was added under stirring. The
precipitate was collected and purified by column chromatography on
silica gel with CH2Cl2 as the eluent, yielding a yellow powder (581
yellow to green-blue EL, with high efficiencies of up to 34.7 cd
A−1 and maximum brightness of up to 256 cd m−2 at 3.0 V,
which are the highest for LECs based on complexes with
phenyl-triazole/tetrazole type C^N ligands and also among the
highest for LECs based on cationic iridium complexes reported
so far, indicating the great potential for the use of tPhTAZ-type
C^N ligands in construction of cationic iridium complexes for
optoelectronic applications.
EXPERIMENTAL SECTION
1
■
mg, 0.54 mmol). Yield: 64%. Mp > 360 °C (dec.). H NMR (400
General Information. Reactants and solvents for synthesis or
measurements were bought from commercial sources and used as
received. Mass spectrometry and elemental analysis were recorded on
a LTQ-ORBITRAP-ETD mass spectrometer and an EA3000
MHz, CDCl3, δ [ppm]): 8.59 (d, J = 8.0 Hz, 2H), 8.20 (d, J = 4.4 Hz,
2H), 8.14 (td, J = 7.8, 1.5 Hz, 2H), 7.71−7.61 (m, 6H), 7.52 (d, J =
7.2 Hz, 2H), 7.44−7.41 (m, 4H), 7.35−7.20 (m, 10H), 6.98 (td, J =
7.5, 1.1 Hz, 2H), 6.75 (t, J = 7.2 Hz, 2H), 6.70 (d, J = 7.6 Hz, 2H),
6.44 (d, J = 7.2 Hz, 2H). 13C NMR (151 MHz, DMSO-d6, δ [ppm]):
163.64, 156.72, 153.91, 152.04, 151.27, 139.63, 133.83, 133.55,
131.82, 131.19, 131.13, 131.02, 130.96, 129.12, 128.96, 128.92,
128.65, 128.37, 125.68, 124.41, 123.47, 122.26. HRMS (ESI, m/z):
941.2649 [M−PF6]+ (calcd 941.2687). Anal. found: C, 55.62; H,
3.48; N, 10.45. Anal. calcd for C50H36F6IrN8P: C, 55.30; H, 3.34; N,
10.32.
1
elemental analyzer (Eurovector, Italy), respectively. H NMR spectra
and 13C NMR spectra were measured on a BRUKER 400/500 NMR
spectrometer and a BRUKER AMX 600-MHz NMR spectrometer,
respectively. Absorption and photoluminescence (PL) spectra were
measured with a UV−vis spectrophotometer (UV-1800, Shanghai
Macy Instrument Co., Ltd.) and a fluorospectrophotometer (F-320,
Tianjin Gangdong Sci. and Tech. Development Co., Ltd.),
respectively. Transient lifetimes for PL were measured with a
steady/transient state spectrofluorometer (FLS1000, Edinburgh
Instruments). Photoluminescent quantum yields (PLQYs) in
degassed solution were measured with quinine sulfate (PLQY =
0.545 in 1 M H2SO4) as the reference. The absolute PLQYs in doped
or neat films were determined on the steady/transient state
spectrofluorometer with an integrating sphere (FLS1000, Edinburgh
Instruments). Experimental details for cyclic voltammetry, X-ray
crystallography, theoretical calculations, and fabrication and character-
Synthesis. 2,5-Diphenyl-1,3,4-oxadiazole was purchased from Alfa
Aesar. 2,5-Bis(4-fluorophenyl)-1,3,4-oxadiazole, 1-methyl-2-(pyridin-
2-yl)-1H-benzo[d]imidazole (mepybi), and 1-phenyl-2-(pyridin-2-yl)-
1H-benzo[d]imidazole (phpybi) were synthesized by reported
procedures.45−47
Synthesis of [Ir(tPhTAZ)2(mepybi)]PF6 (2). The synthesis of
complex 2 followed a procedure similar to that for complex 1, except
that bpy was replaced with mepybi. Yield: 38%. Mp > 360 °C (dec.).
1H NMR (400 MHz, acetone-d6, δ [ppm]): 8.87 (d, J = 7.6 Hz, 1H),
8.48 (d, J = 4.4 Hz, 1H), 8.35 (t, J = 8.0 Hz, 1H), 7.88 (d, J = 8.44 Hz,
1H), 7.81−7.65 (m, 10H), 7.65−7.65 (m, 1H), 7.49 (t, J = 7.6 Hz,
1H), 7.45−7.20 (m, 10H), 7.10 (t, J = 8.0 Hz, 1H), 7.03−6.95 (m,
3H), 6.87 (d, J = 7.2 Hz, 1H), 6.82−6.75 (m, 2H), 6.68 (d, J = 8.0
Hz, 1H), 6.55−6.47 (m, 2H), 4.64 (s, 3H). 13C NMR (151 MHz,
DMSO-d6, δ [ppm]): 163.81, 163.67, 153.89, 153.79, 153.35, 153.27,
152.16, 148.34, 147.76, 140.59, 139.63, 136.74, 134.55, 133.81,
133.78, 133.42, 131.77, 131.44, 131.41, 131.16, 131.11, 131.05,
130.98, 130.94, 130.89, 130.28, 129.07, 129.04, 128.96, 128.82,
128.69, 128.65, 128.35, 125.72, 125.67, 125.65, 124.94, 123.54,
123.35, 122.18, 122.09, 118.15, 112.82, 33.64. HRMS (ESI, m/z):
994.2888 [M−PF6]+ (calcd 994.2952). Anal. found: C, 56.07; H,
3.57; N, 11.03. Anal. calcd for C53H39F6IrN9P: C, 55.88; H, 3.45; N,
11.07.
Synthesis of 3,4,5-Triphenyl-4H-1,2,4-triazole (tPhTAZ). 2,5-
Diphenyl-1,3,4-oxadiazole (2.0 g, 9.0 mmol) and aniline hydro-
chloride (5.8 g, 4.5 mmol) were suspended in N-cyclohexyl-2-
pyrrolidone (5 mL) in a sealed tube. The mixture was stirred at 160
°C under nitrogen for 12 h. To the solution, HCl solution (pH = 2−
3) was added. The precipitate was collected and then recrystallized
from ethanol, affording the pure product as a white solid (2.1 g, 7.1
mmol). Yield: 79%. Mp: 203−204 °C. 1H NMR (500 MHz, DMSO-
d6, δ [ppm]): 7.50−7.35 (m, 15 H). 13C NMR (151 MHz, CDCl3, δ
[ppm]): 154.72, 135.10, 129.99, 129.77, 129.69, 128.86, 128.45,
127.82, 126.69. HRMS (ESI, m/z): 298.1348 [M + H]+ (calcd
298.1339).
Synthesis of [Ir(tPhTAZ)2(phpybi)]PF6 (3). The synthesis of
complex 3 followed a procedure similar to that for complex 1, except
that bpy was replaced with phpybi. Yield: 52%. Mp > 360 °C (dec.).
1H NMR (400 MHz, DMSO-d6, δ [ppm]): 8.33 (d, J = 5.2 Hz, 1H),
8.05 (t, J = 8.0 Hz, 1H), 7.91−7.80 (m, 4H), 7.76−7.60 (m,12H),
7.43−7.26 (m, 12H), 7.2−27.14 (m, 2H), 7.09−7.01 (m, 2H), 6.91
(d, J = 7.6 Hz, 1H), 6.85 (t, J = 7.6 Hz, 1H), 6.82−6.71 (m, 2H), 6.57
(d, J = 8.4 Hz, 1H), 6.39 (d, J = 7.6 Hz,1H), 6.30 (d, J = 8.0 Hz, 1H).
13C NMR (151 MHz, DMSO-d6, δ [ppm]): 163.76, 163.69, 153.93,
153.89, 153.35, 153.02, 151.37, 147.95, 147.37, 140.57, 139.41,
137.69, 134.70, 134.37, 133.84, 133.79, 133.35, 131.90, 131.82,
131.78, 131.46, 131.21, 131.10, 131.03, 130.98, 130.92, 130.34,
129.13, 129.10, 129.02, 129.01, 128.81, 128.77, 128.73, 128.67,
128.48, 128.27, 126.82, 125.73, 125.70, 125.60, 124.49, 123.57,
123.41, 122.27, 118.47, 112.59. HRMS (ESI, m/z): 1056.3031 [M−
PF6]+ (calcd 1056.3109). Anal. found: C, 58.29; H, 3.58; N, 10.56.
Anal. calcd for C58H41F6IrN9P: C, 57.99; H, 3.44; N, 10.49.
Synthesis of [Ir(FtPhTAZ)2(bpy)]PF6 (4). The synthesis of complex
4 followed a procedure similar to that for complex 1, except that
[Ir(tPhTAZ)2Cl]2 was replaced with [Ir(FtPhTAZ)2Cl]2. Yield: 33%.
Synthesis of 3,5-Bis(4-fluorophenyl)-4-phenyl-4H-1,2,4-triazole
(FtPhTAZ). The synthesis of FtPhTAZ followed the same procedure
as that for tPhTAZ, except that 2,5-bis(4-fluorophenyl)-1,3,4-
oxadiazole replaced 2,5-diphenyl-1,3,4-oxadiazole. Mp: 220−221 °C.
1H NMR (500 MHz, DMSO-d6, δ [ppm]): 7.55−7.37 (m, 9H), 7.23
(t, J = 7.8 Hz, 4H). 13C NMR (151 MHz, DMSO-d6, δ [ppm]):
164.02, 162.37, 154.00, 135.04, 131.37, 131.31, 130.41, 128.78,
124.01, 123.99, 116.18, 116.04. HRMS (ESI, m/z): 334.1161 [M +
H]+ (calcd 334.1150).
Synthesis of [Ir(tPhTAZ)2Cl]2. The chloro-bridged iridium dimers
were prepared by following reported procedures.48,49 tPhTAZ (1.0 g,
3.4 mmol) and IrCl3·nH2O (0.5 g, 1.5 mmol) were suspended in 2-
ethoxyethanol/H2O (24/8 mL). The mixture was stirred at 110 °C
under nitrogen for 24 h. The solvent was removed under reduced
pressure. The residual was washed with ethanol (50 mL) under
ultrasonication, affording the crude product as a yellow solid (1.4 g),
which was used for the following reactions without further
purification.
1
Mp > 370 °C (dec.). H NMR (400 MHz, CD3CN, δ [ppm]): 8.51
(d, J = 8.0 Hz, 2H), 8.29−8.22 (m, 2H), 8.16 (t, J = 7.6 Hz, 2H),
7.79−7.62 (m, 8H), 7.61 (d, J = 7.0 Hz, 2H), 7.51 (d, J = 7.6 Hz,
2H), 7.35−7.25 (m, 4H), 7.02 (t, J = 8.0 Hz, 4H), 6.65−6.55 (m,
4H), 6.47 (t, J = 7.0 Hz, 2H). 13C NMR (151 MHz, DMSO-d6, δ
[ppm]): 164.39, 164.37, 162.72, 162.69, 156.59, 154.63, 154.60,
153.22, 152.09, 139.96, 133.46, 132.00, 131.45, 131.39, 131.29,
131.16, 128.86, 128.69, 128.62, 127.70, 125.51, 125.44, 124.49,
122.16, 122.14, 120.10, 119.99, 116.44, 116.29, 109.88, 109.72.
Synthesis of [Ir(FtPhTAZ)2Cl]2. The synthesis of [Ir-
(FtPhTAZ)2Cl]2 followed the same procedure as that for [Ir-
C
Inorg. Chem. XXXX, XXX, XXX−XXX